Synthego:1293873 [24-007185]

Ended Purchase Order Awarded

Contract number
75N95024P00532
Awardee
Awarding agency
Obligated
$35,000

Award facts

Contract value 100% obligated
$35,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Redwood City, CA 94063, USA

Award details come from SAM.gov/FPDS.

About this award

The National Center for Advancing Translational Sciences (NCATS), a civilian agency, awarded a $35,000.00 firm fixed price purchase order contract to Editco Bio Inc., a self-certified small disadvantaged business. The contract, with an ultimate completion date of December 17, 2024, is for the product SYNTHEGO:1293873 [24-007185]. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75N95024P00532?

75N95024P00532 was awarded to Editco Bio Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 3, 2024.

How much is contract 75N95024P00532 worth?

The government has obligated $35,000 on 75N95024P00532.

Which agency awarded contract 75N95024P00532?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00532, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95024P00532 competed?

The extent of competition for 75N95024P00532 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award